Loading
Latest filing published 25 Aug 2023 for Windtree Therapeutics INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Steven Simonson on record concern Windtree Therapeutics Inc, in the capacity of senior executive. In total, 20 filings cover trades dated from 31 March 2015 to 23 August 2023.
The open-market record is one-sided, with 4 purchases worth €12k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 14 share grants.
The median purchase comes to €4,127.
The record was last updated on 25 August 2023 with a share grant in Windtree Therapeutics Inc. The most recent open-market purchase was published on 15 March 2022, 1,684 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations